Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Mario Campone

Showing results (131-140 of 302) with videos related to

Pageof 31
Sort By:
Clinical Breast Cancer|September 15, 2014
Ixabepilone alone or with cetuximab as first-line treatment for advanced/metastatic triple-negative breast cancerOlivier Trédan, Mario Campone, Jacek Jassem, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 27, 2017
Refining the role of pegfilgrastim (a long-acting G-CSF) for prevention of chemotherapy-induced febrile neutropenia: consensus guidance recommendationsMatti Aapro, Ralph Boccia, Robert Leonard, et al.
Breast (Edinburgh, Scotland)|May 4, 2017
Higher antitumor activity of trabectedin in germline BRCA2 carriers with advanced breast cancer as compared to BRCA1 carriers: A subset analysis of a dedicated phase II trialAmal Ghouadni, Suzette Delaloge, Pilar Lardelli, et al.
Cell Death & Disease|December 14, 2020
Anti-PD1 therapy induces lymphocyte-derived exosomal miRNA-4315 release inhibiting Bim-mediated apoptosis of tumor cellsNina Guyon, Delphine Garnier, Joséphine Briand, et al.
Computers in Biology and Medicine|December 14, 2020
Development of an absolute assignment predictor for triple-negative breast cancer subtyping using machine learning approachesFadoua Ben Azzouz, Bertrand Michel, Hamza Lasla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2015
Feasibility and cardiac safety of trastuzumab emtansine after anthracycline-based chemotherapy as (neo)adjuvant therapy for human epidermal growth factor receptor 2-positive early-stage breast cancerIan E Krop, Thomas M Suter, Chau T Dang, et al.
Proteomics|February 14, 2006
Surface-enhanced laser desorption/ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node-negative breast cancer tumorsGabriel Ricolleau, Catherine Charbonnel, Laurence Lodé, et al.
Dose-Response : a Publication of International Hormesis Society|September 25, 2020
Comparison of 4 Screening Methods for Detecting Fluoropyrimidine Toxicity Risk: Identification of the Most Effective, Cost-Efficient Method to Save LivesOlivier Capitain, Valérie Seegers, Jean-Philippe Metges, et al.
Bioinformatics (Oxford, England)|February 1, 2021
Random forest of perfect trees: concept, performance, applications and perspectivesJean-Michel Nguyen, Pascal Jézéquel, Pierre Gillois, et al.
Cell Death & Disease|August 9, 2025
MCL-1 as a molecular switch between myofibroblastic and pro-angiogenic features of breast cancer-associated fibroblastsChloé C Lefebvre, Philippine Giowachini, Jennifer Derrien, et al.
Pageof 31

Showing results (131-140 of 302) with videos related to

Sort By:
Pageof 31
Clinical Breast Cancer|September 15, 2014
Ixabepilone alone or with cetuximab as first-line treatment for advanced/metastatic triple-negative breast cancerOlivier Trédan, Mario Campone, Jacek Jassem, et al.
Supportive Care in Cancer : Official Journal of the Multinational Association of Supportive Care in Cancer|August 27, 2017
Refining the role of pegfilgrastim (a long-acting G-CSF) for prevention of chemotherapy-induced febrile neutropenia: consensus guidance recommendationsMatti Aapro, Ralph Boccia, Robert Leonard, et al.
Breast (Edinburgh, Scotland)|May 4, 2017
Higher antitumor activity of trabectedin in germline BRCA2 carriers with advanced breast cancer as compared to BRCA1 carriers: A subset analysis of a dedicated phase II trialAmal Ghouadni, Suzette Delaloge, Pilar Lardelli, et al.
Cell Death & Disease|December 14, 2020
Anti-PD1 therapy induces lymphocyte-derived exosomal miRNA-4315 release inhibiting Bim-mediated apoptosis of tumor cellsNina Guyon, Delphine Garnier, Joséphine Briand, et al.
Computers in Biology and Medicine|December 14, 2020
Development of an absolute assignment predictor for triple-negative breast cancer subtyping using machine learning approachesFadoua Ben Azzouz, Bertrand Michel, Hamza Lasla, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|February 26, 2015
Feasibility and cardiac safety of trastuzumab emtansine after anthracycline-based chemotherapy as (neo)adjuvant therapy for human epidermal growth factor receptor 2-positive early-stage breast cancerIan E Krop, Thomas M Suter, Chau T Dang, et al.
Proteomics|February 14, 2006
Surface-enhanced laser desorption/ionization time of flight mass spectrometry protein profiling identifies ubiquitin and ferritin light chain as prognostic biomarkers in node-negative breast cancer tumorsGabriel Ricolleau, Catherine Charbonnel, Laurence Lodé, et al.
Dose-Response : a Publication of International Hormesis Society|September 25, 2020
Comparison of 4 Screening Methods for Detecting Fluoropyrimidine Toxicity Risk: Identification of the Most Effective, Cost-Efficient Method to Save LivesOlivier Capitain, Valérie Seegers, Jean-Philippe Metges, et al.
Bioinformatics (Oxford, England)|February 1, 2021
Random forest of perfect trees: concept, performance, applications and perspectivesJean-Michel Nguyen, Pascal Jézéquel, Pierre Gillois, et al.
Cell Death & Disease|August 9, 2025
MCL-1 as a molecular switch between myofibroblastic and pro-angiogenic features of breast cancer-associated fibroblastsChloé C Lefebvre, Philippine Giowachini, Jennifer Derrien, et al.
Pageof 31